{
    "Trade/Device Name(s)": [
        "CareStart Flu A&B Plus",
        "CareStart\u2122 Flu A&B Plus"
    ],
    "Submitter Information": "Access Bio, Inc.",
    "510(k) Number": "K191514",
    "Predicate Device Reference 510(k) Number(s)": [
        "K180438"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSZ"
    ],
    "Summary Letter Date": "February 18, 2020",
    "Summary Letter Received Date": "November 21, 2019",
    "Submission Date": "November 20, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3328"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Antigen Detection Test System"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus nucleoprotein antigen",
        "Influenza B virus nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Extraction vial",
        "Nasopharyngeal swab"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative immunochromatographic detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for CareStart Flu A&B Plus rapid immunochromatographic assay detecting influenza A and B nucleoprotein antigens in nasopharyngeal swabs",
    "Indications for Use Summary": "Qualitative detection of influenza virus type A and B nucleoprotein antigens directly from nasopharyngeal swab specimens of symptomatic patients as an aid in rapid differential diagnosis of acute influenza type A and B viral infections",
    "fda_folder": "Microbiology"
}